Publications

HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.

Abstract

Background: Kaposi's sarcoma (KS) is a common HIV-associated malignancy associated with disability, pain and poor outcomes.

Fardhdiani V Molfino L Zamudio AG Manuel R Luciano G Ciglenecki I Rusch B Toutous Trellu L Coldiron ME
Infectious agents and cancer 2018 ; 13 5. doi: 10.1186/s13027-018-0177-6. Epub 2018 01 19
AIDS-related opportunistic infections Acquired immunodeficiency syndrome Doxorubicin Kaposi sarcoma Mozambique

The new WHO decision-making framework on vaccine use in acute humanitarian emergencies: MSF experience in Minkaman, South Sudan.

Abstract

Introduction: The main causes of death during population movements can be prevented by addressing the population's basic needs.

Rull M Masson S Peyraud N Simonelli M Ventura A Dorion C Luquero FJ Uzzeni F Cigleneki I
Conflict and health 2018 ; 12 11. doi: 10.1186/s13031-018-0147-z. Epub 2018 03 26
Cholera Crude mortality rate Diarrheal diseases Measles Respiratory infections Safe drinking water South Sudan Under 5 mortality rate Vaccine preventable outbreaks

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Abstract

BACKGROUND: The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB.

Bastard M Sanchez-Padilla E du Cros P Khamraev AK Parpieva N Tillyashaykov M Hayrapetyan A Kimenye K Khurkhumal S Dlamini T Perez SF Telnov A Hewison C Varaine F Bonnet M
PloS one 2018 ; 13(3); e0193491. doi: 10.1371/journal.pone.0193491. Epub 2018 03 08
Baraka V Mavoko HM Nabasumba C Francis F Lutumba P Alifrangis M Van Geertruyden JP
PloS one 2018 ; 13(2); e0191922. doi: 10.1371/journal.pone.0191922. Epub 2018 02 01

Oral cholera vaccine in cholera prevention and control, Malawi.

Abstract

PROBLEM: With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being developed.

M'bangombe M Pezzoli L Reeder B Kabuluzi S Msyamboza K Masuku H Ngwira B Cavailler P Grandesso F Palomares A Beck N Shaffer A MacDonald E Senbete M Lessler J Moore SM Azman AS
Bulletin of the World Health Organization 2018 Jun 01; 96(6); . doi: 10.2471/BLT.17.207175. Epub 2018 04 23

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.

Abstract

BACKGROUND: Cholera remains a persistent health problem in sub-Saharan Africa and worldwide.

Lessler J Moore SM Luquero FJ McKay HS Grais R Henkens M Mengel M Dunoyer J M'bangombe M Lee EC Djingarey MH Sudre B Bompangue D Fraser RSM Abubakar A Perea W Legros D Azman AS
Lancet (London, England) 2018 05 12; 391(10133); 1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 03 01

Near real-time forecasting for cholera decision making in Haiti after Hurricane Matthew.

Abstract

Computational models of cholera transmission can provide objective insights into the course of an ongoing epidemic and aid decision making on allocation of health care resources.

Pasetto D Finger F Camacho A Grandesso F Cohuet S Lemaitre JC Azman AS Luquero FJ Bertuzzo E Rinaldo A
PLoS computational biology 2018 05 ; 14(5); e1006127. doi: 10.1371/journal.pcbi.1006127. Epub 2018 05 16

Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.

Abstract

INTRODUCTION: Oral cholera vaccines are primarily recommended by the World Health Organization for cholera control in endemic countries.

Massing LA Aboubakar S Blake A Page AL Cohuet S Ngandwe A Mukomena Sompwe E Ramazani R Allheimen M Levaillant P Lechevalier P Kashimi M de la Motte A Calmejane A Bouhenia M Dabire E Bompangue D Kebela B Porten K Luquero F
PLoS neglected tropical diseases 2018 05 ; 12(5); e0006369. doi: 10.1371/journal.pntd.0006369. Epub 2018 05 07

Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.

Abstract

BACKGROUND: Residual systemic inflammation persists despite suppressive antiretroviral therapy (ART) and is associated with non-AIDS clinical outcomes.

Castillo-Mancilla JR Morrow M Boum Y Byakwaga H Haberer JE Martin JN Bangsberg D Mawhinney S Musinguzi N Huang Y Tracy RP Burdo TH Williams K Muzzora C Hunt PW Siedner MJ
Journal of acquired immune deficiency syndromes (1999) 2018 Apr 15; 77(5); 507-513. doi: 10.1097/QAI.0000000000001629. Epub 2018 11 13